ea0073d2.2 | Debate 2: CGM for all people with diabetes? | ECE2021
Laviola Luigi
In people with diabetes, optimizing glucose control is critical to reduce the risk of both acute and chronic complications. Technologies measuring interstitial glucose concentrations provide professional teams and patients with glucose data and interpretation tools which can improve metabolic control and optimize therapy management. There is strong evidence supporting both rtCGM and FGM use in people with type 1 diabetes (T1DM), with benefits of reduced HbA1c and hypoglycaemia...